6535.TWO · LUMOSA
Taiwan · RS rating 7 · As of 2026-10-08
| Price | 81.30 TWD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 69 / 10 / 1 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 13 / 9 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -34.7% |
| Sales growth Q/Q | +14.4% |
| Distance from 52-week high | +74.5% |
| Market cap (USD) | $445.8M |